Reliability and discriminant validity of HER2 gene quantification and chromosome 17 aneusomy analysis by real-time PCR in primary breast cancer

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT

1951 • 319,299 citations

An Analysis of Transformations

1964 • 13,718 citations

Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene

1987 • 11,429 citations

Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

2005 • 5,199 citations

Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer

2005 • 4,901 citations

Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease

1999 • 2,747 citations

c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast Cancer

1994 • 981 citations

2000 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology*

2001 • 882 citations

erbB-2 and Response to Doxorubicin in Patients With Axillary Lymph Node-Positive, Hormone Receptor- Negative Breast Cancer

1998 • 667 citations

The HER-2/neu Gene and Protein in Breast Cancer 2003: Biomarker and Target of Therapy

2003 • 604 citations

Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization.

1996 • 564 citations

Real-World Performance of HER2 Testing--National Surgical Adjuvant Breast and Bowel Project Experience

2002 • 492 citations

ERBB2 oncogene in human breast cancer and its clinical significance

1998 • 457 citations

c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases.

1996 • 423 citations

Concordance Between Local and Central Laboratory HER2 Testing in the Breast Intergroup Trial N9831

2002 • 401 citations

Real-Time PCR Analysis of DNA and RNA Extracted from Formalin-Fixed and Paraffin-Embedded Biopsies

2001 • 397 citations

p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity.

1986 • 341 citations

Fluorescence in situ hybridization

1993 • 308 citations

Trastuzumab

2002 • 284 citations

HER-2 Amplification, HER-1 Expression, and Tamoxifen Response in Estrogen Receptor-Positive Metastatic Breast Cancer

2004 • 256 citations

New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays.

2001 • 218 citations

HER2 Testing in Patients With Breast Cancer: Poor Correlation Between Weak Positivity by Immunohistochemistry and Gene Amplification by Fluorescence In Situ Hybridization

2002 • 193 citations

Overexpression of HER-2 as a resistance mechanism to hormonal therapy for breast cancer.

2001 • 172 citations

HER-2/neu as a Predictive Marker in a Population of Advanced Breast Cancer Patients Randomly Treated Either with Single-agent Doxorubicin or Single-agent Docetaxel

2004 • 139 citations

Aneusomy 17 in Breast Cancer: Its Role in HER-2/neu Protein Expression and Implication for Clinical Assessment of HER-2/neu Status

2002 • 138 citations

Chromosome 17 Aneusomy is Associated with Poor Prognostic Factors in Invasive Breast Carcinoma

2003 • 132 citations

NCCN Practice Guidelines for Breast Cancer.

2000 • 113 citations

Real-Time Quantitative PCR of Microdissected Paraffin-Embedded Breast Carcinoma

2004 • 110 citations

Impact of Polysomy 17 on HER-2/neu Immunohistochemistry in Breast Carcinomas without HER-2/neu Gene Amplification

2003 • 107 citations

HER2 Assessment by Immunohistochemical Analysis and Fluorescence In Situ Hybridization

2002 • 95 citations

Prognostic and Predictive Significance of ErbB-2 Breast Tumor Levels Measured by Enzyme Immunoassay

2001 • 91 citations

A computer program for non-parametric receiver operating characteristic analysis

1993 • 87 citations

Relationship between c-erbB-2 and other tumor characteristics in breast cancer prognosis.

2000 • 87 citations

Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situhybridization and immunohistochemistry

2005 • 85 citations

Her-2/neu Gene Amplification in Low to Moderately Expressing Breast Cancers: Possible Role of Chromosome 17/Her-2/neu Polysomy

2001 • 78 citations

Conference summary, Strategic Science symposium. Her-2/neu testing of breast cancer patients in clinical practice.

2003 • 66 citations

HER-2/neu Gene Copy Number Quantified by Real-Time PCR: Comparison of Gene Amplification, Heterozygosity, and Immunohistochemical Status in Breast Cancer Tissue

2003 • 65 citations

c-erbB-2 Positivity is a factor for poor prognosis in breast cancer and poor response to hormonal or chemotherapy treatment in advanced disease

2001 • 64 citations

c-erbB-2 oncoprotein overexpression identifies a subgroup of estrogen receptor positive (ER +) breast cancer patients with poor prognosis

2001 • 64 citations

Predicting response to adjuvant and radiation therapy in patients with early stage breast carcinoma

1998 • 56 citations

Her2/neu Expression Predicts the Response to Antiaromatase Neoadjuvant Therapy in Primary Breast Cancer

2004 • 53 citations

Comparison of Two Quantitative Polymerase Chain Reaction Methods for Detecting HER2/neu Amplification

2003 • 52 citations

ADJUVANT THERAPY WITH TAMOXIFEN IN OPERABLE BREAST CANCER

1988 • 52 citations

Progesterone Receptor Quantification as a Strong Prognostic Determinant in Postmenopausal Breast Cancer Women under Tamoxifen Therapy

2002 • 50 citations

Conference Summary, Strategic Science Symposium

2003 • 50 citations

Concomitant gastrin and ERBB2 gene amplifications at 17q12-q21 in the intestinal type of gastric cancer

1999 • 38 citations

Evaluation of HER-2/neu in Serum and Tissue of Primary and Metastatic Breast Cancer Patients using an Automated Enzyme Immunoassay

2001 • 37 citations

ErbB2 assay in breast cancer: possibly improved clinical information using a quantitative method.

1997 • 37 citations

Clinicopathologic analysis of breast carcinoma with chromosomal aneusomy detected by fluorescence in situ hybridization

2001 • 35 citations

Quantitative PCR – new diagnostic tool for quantifying specific mRNA and DNA molecules: HER2/neuDNA quantification with LightCycler real‐time PCR in comparison with immunohistochemistry and fluorescencein situhybridization

2004 • 32 citations

Evaluation of HER2/neuStatus by Real-Time Quantitative PCR in Breast Cancer

2002 • 25 citations

Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up.

2002 • 23 citations

Interobserver Reproducibility of Immunohistochemical Her-2/Neu Evaluation in Human Breast Cancer: The Real-World Experience

2004 • 22 citations

Assignment of v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (ERBB2) to human chromosome band 17q21.1 by in situ hybridization

1997 • 22 citations

Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.

1997 • 21 citations

Interobserver Reproducibility of Immunohistochemical Her-2/Neu Assessment in Human Breast Cancer: An Update from INQAT round III

2005 • 18 citations

Prognostic impact of cathepsin D and c-erbB-2 oncoprotein in a subgroup of node-negative breast cancer patients with low histological grade tumors

2001 • 18 citations

Fluorescence <I>In Situ</I> Hybridization: <I>Technical Overview<I>

2004 • 16 citations